Research programme: small molecule therapeutics - Sirenas Marine Discovery
Latest Information Update: 28 Nov 2020
Price :
$50 *
At a glance
- Originator Sirenas Marine Discovery
- Class Small molecules
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Cancer; Infections
Most Recent Events
- 28 Nov 2020 No recent reports of development identified for research development in Cancer in USA
- 28 Jul 2018 No recent reports of development identified for preclinical development in Infections in USA
- 18 Oct 2016 Early research in Cancer in USA (unspecified route)